Leila Alland Pmv Pharmaceuticals, Inc. (PMVP) insider trading activity

Leila Alland is Chief Medical Officer of PMV Pharmaceuticals, Inc.. Currently has a direct ownership of 45,909 shares of PMVP, which is worth approximately $69,322. The most recent transaction as insider was on Sep 15, 2023, when has been sold 6,291 shares (Common Stock) at a price of $6.62 per share, resulting in proceeds of $41,646. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.9K

0% 3M change

0% 12M change

Total Value Held $69,322

Leila Alland Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 15 2023	SELL Open market or private sale	$41,646 $6.62 p/Share	6,291 Reduced 12.05%	45,909 Common Stock
Sep 09 2022	BUY Grant, award, or other acquisition	-	52,200 Added 50.0%	52,200 Common Stock
Sep 09 2021	SELL Open market or private sale	$3,025 $30.25 p/Share	100 Reduced 100.0%	0 Common Stock
Sep 09 2021	BUY Exercise of conversion of derivative security	$390 $3.9 p/Share	100 Added 50.0%	100 Common Stock
Sep 07 2021	SELL Open market or private sale	$117,975 $30.25 p/Share	3,900 Reduced 100.0%	0 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$15,210 $3.9 p/Share	3,900 Added 50.0%	3,900 Common Stock
Aug 09 2021	SELL Open market or private sale	$155,591 $34.8 p/Share	4,471 Reduced 100.0%	0 Common Stock
Aug 09 2021	BUY Exercise of conversion of derivative security	$15,600 $3.9 p/Share	4,000 Added 50.0%	4,000 Common Stock
Jul 07 2021	SELL Open market or private sale	$129,200 $32.3 p/Share	4,000 Reduced 100.0%	0 Common Stock
Jul 07 2021	BUY Exercise of conversion of derivative security	$15,600 $3.9 p/Share	4,000 Added 50.0%	4,000 Common Stock
Jun 07 2021	SELL Open market or private sale	$134,800 $33.7 p/Share	4,000 Reduced 100.0%	0 Common Stock
Jun 07 2021	BUY Exercise of conversion of derivative security	$15,600 $3.9 p/Share	4,000 Added 50.0%	4,000 Common Stock
May 07 2021	SELL Open market or private sale	$140,600 $35.15 p/Share	4,000 Reduced 100.0%	0 Common Stock
May 07 2021	BUY Exercise of conversion of derivative security	$15,600 $3.9 p/Share	4,000 Added 50.0%	4,000 Common Stock
Apr 07 2021	SELL Open market or private sale	$136,560 $34.14 p/Share	4,000 Reduced 100.0%	0 Common Stock
Apr 07 2021	BUY Exercise of conversion of derivative security	$15,600 $3.9 p/Share	4,000 Added 50.0%	4,000 Common Stock

Also insider at

ABEO

ABEONA THERAPEUTICS INC. Healthcare

Director

Leila Alland

Chief Medical Officer

Cranbury, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PMVP shares.

Notify only if

Value

Insider Trading

Get notified when an Pmv Pharmaceuticals, Inc. insider buys or sells PMVP shares.

Notify only if

Operation

Value

Type

News

Receive news related to PMV Pharmaceuticals, Inc.

Track Activities on PMVP

Account